Tinhofer I - Search Results

1

Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice.

Keller M, Simbruner G, Górna A, Urbanek M, Tinhofer I, Griesmaier E, Sarkozy G, Schwendimann L, Gressens P. Keller M, et al. Among authors: tinhofer i. Pediatr Res. 2006 Apr;59(4 Pt 1):549-53. doi: 10.1203/01.pdr.0000205152.38692.81. Pediatr Res. 2006. PMID: 16549527

2

Tetrocarcin-A--induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2--independent pathway.

Anether G, Tinhofer I, Senfter M, Greil R. Anether G, et al. Among authors: tinhofer i. Blood. 2003 Jun 1;101(11):4561-8. doi: 10.1182/blood-2002-08-2501. Epub 2003 Jan 30. Blood. 2003. PMID: 12560233 Free article.

3

Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells.

Bernhard D, Schwaiger W, Crazzolara R, Tinhofer I, Kofler R, Csordas A. Bernhard D, et al. Among authors: tinhofer i. Cancer Lett. 2003 Jun 10;195(2):193-9. doi: 10.1016/s0304-3835(03)00157-5. Cancer Lett. 2003. PMID: 12767528

4

Stressful death of T-ALL tumor cells after treatment with the anti-tumor agent Tetrocarcin-A.

Tinhofer I, Anether G, Senfter M, Pfaller K, Bernhard D, Hara M, Greil R. Tinhofer I, et al. FASEB J. 2002 Aug;16(10):1295-7. doi: 10.1096/fj.02-0020fje. Epub 2002 Jun 7. FASEB J. 2002. PMID: 12060673

5

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.

Asslaber D, Piñón JD, Seyfried I, Desch P, Stöcher M, Tinhofer I, Egle A, Merkel O, Greil R. Asslaber D, et al. Among authors: tinhofer i. Blood. 2010 May 27;115(21):4191-7. doi: 10.1182/blood-2009-07-234823. Epub 2010 Jan 20. Blood. 2010. PMID: 20089965 Free article.

6

Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia.

Anether G, Marschitz I, Tinhofer I, Greil R. Anether G, et al. Among authors: tinhofer i. Blood. 2002 Jan 15;99(2):722-3. doi: 10.1182/blood.v99.2.722. Blood. 2002. PMID: 11799965 Free article. No abstract available.

7

Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.

Greil R, Anether G, Johrer K, Tinhofer I. Greil R, et al. Among authors: tinhofer i. J Leukoc Biol. 2003 Sep;74(3):311-30. doi: 10.1189/jlb.0802416. J Leukoc Biol. 2003. PMID: 12949235 Review.

8

Tuning the rheostat of the myelopoietic system via Fas and TRAIL.

Greil R, Anether G, Johrer K, Tinhofer I. Greil R, et al. Among authors: tinhofer i. Crit Rev Immunol. 2003;23(4):301-22. doi: 10.1615/critrevimmunol.v23.i4.30. Crit Rev Immunol. 2003. PMID: 14700272 Review.

9

Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.

Tinhofer I, Rubenzer G, Holler C, Hofstaetter E, Stoecher M, Egle A, Steurer M, Greil R. Tinhofer I, et al. Blood. 2006 Nov 1;108(9):2950-6. doi: 10.1182/blood-2006-03-010553. Epub 2006 Jul 6. Blood. 2006. PMID: 16825496 Free article.

10

Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.

Merkel O, Heyder C, Asslaber D, Hamacher F, Tinhofer I, Holler C, Stöcher M, Prokesch A, Papak C, Scheideler M, Trajanoski Z, Greil R. Merkel O, et al. Among authors: tinhofer i. J Mol Med (Berl). 2008 May;86(5):541-52. doi: 10.1007/s00109-008-0314-6. Epub 2008 Feb 23. J Mol Med (Berl). 2008. PMID: 18297255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters